Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000394407

Medchemexpress LLC 1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro- | 2543673-19-2 | 99.7% | 535.60 | 500 MG
SDP

Catalog No. 5000394407
Encompass_Preferred

DCC-3116 is an orally active ULK1/2 inhibitor. It inhibits autophagy in lung cancer cells by targeting KRASG12C signaling, which in turn inhibits the proliferation of lung cancer cells and exhibits anti-cancer effects.

  • Orally active ULK1/2 inhibitor.
  • Inhibits autophagy in lung cancer cells.
  • Inhibits KRASG12C signaling.
  • Exerts anti-cancer effects.
  • Available in various quantities.

Catalog No. 50-003-94407 Supplier Medchemexpress LLC Supplier No. HY160699500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

DCC-3116 is an orally active ULK1/2 inhibitor. It inhibits autophagy in lung cancer cells by targeting KRASG12C signaling, which in turn inhibits the proliferation of lung cancer cells and exhibits anti-cancer effects.

  • Orally active ULK1/2 inhibitor.
  • Inhibits autophagy in lung cancer cells.
  • Inhibits KRASG12C signaling.
  • Exerts anti-cancer effects.
  • Available in various quantities.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.